Flibanserin
CAS 167933-07-5 1 FDA-DMF supplierSmall Molecule
Overview
Flibanserin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL231068).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Flibanserin expires 8 May 2028 and exclusivity 13 Dec 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one
- Canonical SMILES
- C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F
- InChIKey
- PPRRDFIXUUSXRA-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.